Skip to main content
. 2023 Feb 9;13(2):295. doi: 10.3390/brainsci13020295

Table 2.

Comparison and logistic regression analysis of biochemical data between the PSF and no-PSF groups.

Laboratory Parameters PSF Group No-PSF Group p
Lesion location, n (%) 0.032 *
 Cerebral cortex 10 (13.7) 28 (17.8)
 Limbic system 6 (8.2) 16 (10.2)
 Basal ganglia 32 (43.8) 67 (42.7)
 Cerebellum 15 (20.5) 25 (15.9)
 Brainstem 10 (13.7) 21 (13.4)
Anxiety (HAMA score ≥ 7), n (%) 38 (52.1) 36 (22.9) <0.001 *
Depression (HADA score ≥ 7), n (%) 41 (56.2) 42 (26.8) <0.001 *
Cognitive impairment (MoCA score < 26), n (%) 36 (49.3) 59 (37.6) 0.677
Sleep disorders (PSQI), mean (SD) 11.4 (4.3) 7.4 (3.6) <0.001 *
FPG, mean (SD), mmol/L 8.85 (1.96) 5.86 (1.65) <0.001 **
TG, mean (SD), mmol/L 1.72 (0.76) 1.66 (0.74) 0.563
TC, mean (SD), mmol/L 5.23 (1.09) 5.02 (1.01) 0.647
LDL-C, mean (SD), mmol/L 3.30 (0.89) 2.96 (0.83) 0.450
HDL-C, mean (SD), mmol/L 1.12 (0.27) 1.11 (0.29) 0.797
UA, mean (SD), µmol/L 285.67 (80.70) 332.11 (82.68) <0.001 **
FIB, mean (SD), g/L 3.55 (0.81) 3.50 (0.80) 0.374
HCY, mean (SD), μmol/L 24.64 (8.47) 16.32 (6.06) <0.001 **
FT4, mean (SD), pmol/L 17.22 (4.13) 16.89 (3.79) 0.342
TSH, mean (SD), µU/mL 3.00 (1.56) 2.58 (1.26) 0.278
Variables β SE3 Wald χ2 p OR 95% CI
Female sex 0.897 0.294 4.524 0.030 2.12 1.14–3.94
Sleep disorders 0.265 0.142 6.020 0.010 1.50 1.01–1.73
Depressive state 0.398 0.138 5.686 0.002 1.58 1.01–1.98

HAMA, Hamilton Anxiety Scale; HAMD, Hamilton Depression Rating Scale; MoCA, Montreal Cognitive Assessment; PSQI, Pittsburgh Sleep Quality Index; SD, standard deviation; FPG, fasting plasma glucose; TG, triglyceride; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; UA, uric acid; FIB, fibrinogen; HCY, homocysteine; FT4, free thyroxine; TSH, thyroid-stimulating hormone; SD, standard deviation; SE, standard error; OR, odds ratio; CI confidence interval. * p < 0.05; ** p < 0.001.